The troriluzole clinical development program encompassed the first industry clinical trials to generate data showing ...
Children and young people have higher risks of rare vascular and inflammatory diseases up to 12 months after a first COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback